Home Cart Sign in  
Chemical Structure| 2869954-98-1 Chemical Structure| 2869954-98-1

Structure of 2869954-98-1

Chemical Structure| 2869954-98-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Werner syndrome RecQ helicase-IN-3 is an orally active WRN inhibitor with an IC50 of 0.06 µM. It demonstrates significant anti-proliferative activity, suitable for cancer treatment research targeting WRN, especially in anti-proliferative related tumor therapies.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Werner syndrome RecQ helicase-IN-3

CAS No. :2869954-98-1
Formula : C31H30ClF3N8O5
M.W : 687.07
SMILES Code : O=C(NC1=CC=C(C(F)(F)F)C=C1Cl)CN(C(CC)=C2N3CCN(C(C4=NC=CC=C4O)=O)CC3)C5=NC(C6=CCOCC6)=NN5C2=O
MDL No. :N/A

Safety of Werner syndrome RecQ helicase-IN-3

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Werner syndrome RecQ helicase-IN-3

DNA

Isoform Comparison

Biological Activity

Description
Werner syndrome RecQ helicase-IN-3 is a potent and orally active inhibitor of Werner syndrome RecQ helicase (WRN), with an IC50 value of 0.06 µM. It exhibits antiproliferative and anticancer activities[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.46mL

0.29mL

0.15mL

7.28mL

1.46mL

0.73mL

14.55mL

2.91mL

1.46mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories